5.43

1.31% 0.07

Voyager Therapeutics Inc (VYGR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$5.36

Aprire:

$5.35

Volume 24 ore:

335.43K

Relative Volume:

0.61

Capitalizzazione di mercato:

$295.52M

Reddito:

$163.78M

Utile/perdita netta:

$25.88M

Rapporto P/E:

2.3921

EPS:

2.27

Flusso di cassa netto:

$-28.66M

1 W Prestazione:

-12.70%

1M Prestazione:

-29.11%

6M Prestazione:

-35.66%

1 anno Prestazione:

-19.08%

Intervallo 1D:

$5.19

$5.49

Intervallo di 1 settimana:

$5.19

$6.1499

Portata 52W:

$5.19

$11.72

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Nome

Voyager Therapeutics Inc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

857-259-5340

Indirizzo

75 HAYDEN AVENUE, LEXINGTON, MA

Dipendente

162

Cinguettio

@VoyagerTx

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

VYGR's Discussions on Twitter

Confronta VYGR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VYGR	5.43	295.52M	163.78M	25.88M	-28.66M	2.27
VRTX	449.99	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	747.10	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	591.88	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	246.13	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	107.68	24.89B	3.30B	-501.07M	1.03B	11.54

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-05-10	Iniziato	Truist	Buy
2023-03-10	Iniziato	Oppenheimer	Outperform
2021-10-07	Aggiornamento	Robert W. Baird	Neutral → Outperform
2021-02-26	Downgrade	Robert W. Baird	Outperform → Neutral
2021-02-03	Downgrade	BTIG Research	Buy → Neutral
2021-02-03	Downgrade	Wedbush	Outperform → Neutral
2020-12-24	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2020-12-23	Downgrade	Raymond James	Outperform → Mkt Perform
2020-11-11	Downgrade	Oppenheimer	Outperform → Perform
2020-11-10	Downgrade	Raymond James	Strong Buy → Outperform
2020-11-10	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-03-19	Iniziato	The Benchmark Company	Buy
2020-02-06	Iniziato	Oppenheimer	Outperform
2018-11-15	Aggiornamento	Raymond James	Outperform → Strong Buy
2018-09-10	Ripresa	BTIG Research	Buy
2018-09-10	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2018-06-04	Iniziato	H.C. Wainwright	Buy
2018-03-12	Downgrade	Evercore ISI	Outperform → In-line
2018-03-12	Downgrade	Wedbush	Outperform → Neutral
2018-02-02	Iniziato	Morgan Stanley	Overweight
2017-11-28	Ripresa	Piper Jaffray	Overweight
2017-10-31	Iniziato	Robert W. Baird	Outperform
2017-10-27	Iniziato	Canaccord Genuity	Buy
2017-10-23	Reiterato	Stifel	Buy
2017-10-12	Iniziato	Raymond James	Outperform
2017-08-17	Iniziato	Evercore ISI	Outperform
2017-07-28	Ripresa	Stifel	Buy

Mostra tutto

Voyager Therapeutics Inc Borsa (VYGR) Ultime notizie

Nov 20, 2024

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease - GlobeNewswire

Nov 20, 2024

Voyager's New Alzheimer's Gene Therapy Shows 73% Tau Reduction in Key Study | VYGR Stock News - StockTitan

Nov 20, 2024

Nov 18, 2024

Voyager Therapeutics’ TRACER Platform Targets CNS Market: Here’s Why I’m Neutral (VYGR) - Seeking Alpha

Nov 18, 2024

StockNews.com Upgrades Voyager Therapeutics (NASDAQ:VYGR) to "Buy" - MarketBeat

Nov 18, 2024

FY2024 Earnings Forecast for VYGR Issued By HC Wainwright - MarketBeat

Nov 18, 2024

Nov 17, 2024

Voyager Therapeutics’ (VYGR) Buy Rating Reiterated at Canaccord Genuity Group - Defense World

Nov 17, 2024

Voyager Therapeutics’ (VYGR) Buy Rating Reiterated at HC Wainwright - Defense World

Nov 17, 2024

Nov 15, 2024

Voyager Therapeutics' (VYGR) Buy Rating Reiterated at Canaccord Genuity Group - MarketBeat

Nov 14, 2024

Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

Nov 14, 2024

Voyager Therapeutics (NASDAQ:VYGR) Earns Buy Rating from HC Wainwright - MarketBeat

Nov 14, 2024

Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)? - Yahoo Finance

Nov 14, 2024

Nov 13, 2024

Earnings call: Voyager Therapeutics focuses on neurological therapies By Investing.com - Investing.com Canada

Nov 13, 2024

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Voyager Therapeutics: Q3 Earnings Snapshot - Darien Times

Nov 13, 2024

Voyager Therapeutics Inc earnings beat by $0.29, revenue topped estimates - Investing.com Australia

Nov 13, 2024